Item Type | Name |
Concept
|
Autoimmune Diseases
|
Concept
|
Connective Tissue Diseases
|
Concept
|
Chronic Disease
|
Concept
|
Disease Susceptibility
|
Concept
|
Lung Diseases
|
Concept
|
Disease Management
|
Concept
|
Mediastinal Diseases
|
Concept
|
Disease Progression
|
Concept
|
Lung Diseases, Interstitial
|
Concept
|
Pulmonary Disease, Chronic Obstructive
|
Concept
|
Disease Models, Animal
|
Concept
|
Mixed Connective Tissue Disease
|
Concept
|
Genetic Predisposition to Disease
|
Academic Article
|
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4.
|
Academic Article
|
Clinical characteristics of patients with anti-Jo-1 antibodies: a single center experience.
|
Academic Article
|
Allergic bronchopulmonary aspergillosis.
|
Academic Article
|
Autoimmune-featured interstitial lung disease: a distinct entity.
|
Academic Article
|
Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis.
|
Academic Article
|
Bronchiectasis in a diverse US population: effects of ethnicity on etiology and sputum culture.
|
Academic Article
|
Pathologic quantification of connective tissue disease-associated versus idiopathic usual interstitial pneumonia.
|
Academic Article
|
Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.
|
Academic Article
|
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
|
Academic Article
|
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial.
|
Academic Article
|
Thyroid Disease Is Prevalent and Predicts Survival in Patients With Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
|
Academic Article
|
TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease.
|
Academic Article
|
Response.
|
Academic Article
|
Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features.
|
Academic Article
|
Characterisation of patients with interstitial pneumonia with autoimmune features.
|
Academic Article
|
Interstitial pneumonia with autoimmune features: a critical appraisal of the new definition.
|
Academic Article
|
Comprehensive Care of the Lung Transplant Patient.
|
Academic Article
|
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease.
|
Academic Article
|
Therapeutic Approach to Adult Fibrotic Lung Diseases.
|
Academic Article
|
Interstitial pneumonia with autoimmune features: Clinical, radiologic, and histological characteristics and outcome in a series of 57 patients.
|
Academic Article
|
A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria.
|
Academic Article
|
CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features.
|
Academic Article
|
ICOS protects against mortality from acute lung injury through activation of IL-5+ ILC2s.
|
Academic Article
|
CT findings associated with survival in chronic hypersensitivity pneumonitis.
|
Academic Article
|
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis.
|
Academic Article
|
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort.
|
Academic Article
|
Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography.
|
Academic Article
|
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation.
|
Academic Article
|
Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort.
|
Academic Article
|
Systemic sclerosis-associated interstitial lung disease: Role of the oesophagus in outcomes.
|
Academic Article
|
Pharmacological management of progressive-fibrosing interstitial lung diseases: a review of the current evidence.
|
Academic Article
|
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.
|
Academic Article
|
Proceedings of the American College of Rheumatology/Association of Physicians of Great Britain and Ireland Connective Tissue Disease-Associated Interstitial Lung Disease Summit: A Multidisciplinary Approach to Address Challenges and Opportunities.
|
Academic Article
|
Telomere length and genetic variant associations with interstitial lung disease progression and survival.
|
Academic Article
|
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
|
Academic Article
|
Anti-RNA binding protein positivity in idiopathic interstitial pneumonia.
|
Academic Article
|
Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Occupational Burden in Chronic Respiratory Disease: Call for Recognition, Training, and Data Capture.
|
Academic Article
|
Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease.
|
Academic Article
|
Recent Advances in Severe Asthma: From Phenotypes to Personalized Medicine.
|
Academic Article
|
Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis.
|
Academic Article
|
Diagnostic test interpretation and referral delay in patients with interstitial lung disease.
|
Academic Article
|
Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease.
|
Academic Article
|
CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA.
|
Academic Article
|
Gender equity in interstitial lung disease.
|
Academic Article
|
Automated CT Analysis of Major Forms of Interstitial Lung Disease.
|
Academic Article
|
Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.
|
Academic Article
|
Blood Transcriptomics Predicts Progression of Pulmonary Fibrosis and Associated Natural Killer Cells.
|
Academic Article
|
Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT.
|
Academic Article
|
The other connective tissue disease-associated interstitial lung diseases: Sjogren's syndrome, mixed connective tissue disease, and systemic lupus erythematosus.
|
Academic Article
|
Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.
|
Academic Article
|
Differentiation of Idiopathic Pulmonary Fibrosis from Connective Tissue Disease-Related Interstitial Lung Disease Using Quantitative Imaging.
|
Academic Article
|
Hypersensitivity pneumonitis: Current concepts in pathogenesis, diagnosis, and treatment.
|
Academic Article
|
High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
|
Academic Article
|
Lung function trajectory in progressive fibrosing interstitial lung disease.
|
Academic Article
|
Association of antinuclear antibody seropositivity with inhaled environmental exposures in patients with interstitial lung disease.
|
Academic Article
|
Occupational Exposures in Rheumatoid Arthritis-related Airway Disease: A Missing Link?
|
Academic Article
|
Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.
|
Academic Article
|
Interstitial Lung Disease in Firefighters: An Emerging Occupational Hazard.
|
Academic Article
|
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
|
Academic Article
|
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
|
Academic Article
|
Mortality Risk From COVID-19 Among Unvaccinated Subjects With Autoimmune Phenotypes of Interstitial Lung Disease.
|
Academic Article
|
Expert consensus on the management of systemic sclerosis-associated interstitial lung disease.
|
Academic Article
|
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.
|
Academic Article
|
PhIP-Seq uncovers novel autoantibodies and unique endotypes in interstitial lung disease.
|
Academic Article
|
Antigenic responses are hallmarks of fibrotic interstitial lung diseases independent of underlying etiologies.
|
Academic Article
|
Treatable traits: a comprehensive precision medicine approach in interstitial lung disease.
|
Academic Article
|
Integrative multi-omics analysis reveals novel idiopathic pulmonary fibrosis endotypes associated with disease progression.
|
Academic Article
|
Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.
|
Academic Article
|
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease.
|
Academic Article
|
Associations of Plasma Omega-3 Fatty Acids With Progression and Survival in Pulmonary Fibrosis.
|
Academic Article
|
Risk Factors for Hospital Readmission in Patients with Interstitial Lung Disease.
|
Academic Article
|
Machine Learning of Plasma Proteomics Classifies Diagnosis of Interstitial Lung Disease.
|